News
Finding May Help Predict Pancreatic NET Recurrence
NETRF-funded researchers identified a cancer cell type that is associated with non-functional pancreatic neuroendocrine tumor (pNET) recurrence. Alpha-like pNET cell expression of the protein ARX can guide prognosis.
Grant Applications Go to Board of Scientific Advisors
NETRF’s Board of Scientific Advisors and external reviewers will begin reading and ranking the 2019 requests for research funding. Wide Range of Requests for NET
NETRF Welcomes John Kanki, PhD, as New Research Director
John Kanki, PhD, has joined Neuroendocrine Tumor Research Foundation (NETRF) as Director of Research. In this position, Dr. Kanki will oversee the strategic, scientific, and
In Memory of Carol Branaman
Neuroendocrine cancer community faces loss. Carol Branaman, vice chair and former chair of NETRF, passes from neuroendocrine cancer.
Rocks that Bring Hope
From a place of discouragement after being diagnosed with a NET in June 2018, Susan Garrett of Roxboro, NC, saw a news story on WRAL
FAQs Neuroendocrine Tumor Tissue Donation
The need for tumor tissue in NETs The Neuroendocrine Tumor Research Foundation is on a mission to fill the urgent need for more neuroendocrine tumor
NETRF 2019 Research Symposium
Latest in NET Cancer Research Neuroendocrine Tumor Research Foundation (NETRF) held its 11th Annual Research Symposium on May 2-3, 2019, in Cambridge, MA. More than
2019 NET Research Grants
NETRF Announces 2019 Neuroendocrine Cancer Research Funding Opportunities New award to fund early career investigators The Neuroendocrine Tumor Research Foundation (NETRF) has announced a new
Developing a NET Cell Line
NETRF & Broad Institute Work to Fill Research Void The lack of publicly available, reliable NET cell lines is a barrier in neuroendocrine tumor research,
Exploring Targeted Alpha Therapy for Neuroendocrine Tumors
Increasing Precision in Cancer Cell Death to Prevent Metastasis In housework and lawn work, it is important to have the right tool for the job.